DRUG RELATED PROBLEM IN PATIENT WITH HYPERTENSION HEART DESEASE (HHD) AND PARAPARESE INFERIOR DISEASE AT MINTOHARJO HOSPITAL JAKARTA.

Autor: Widodo, Jefri Tri, Efi, Aprilita Rinayanti, LailaRahmatillah, Diana
Zdroj: Wood Industry / Drvna Industrija; 2015 Supplement1, Vol. 6 Issue 1, p1896-1901, 6p
Abstrakt: Paraparese inferior is paralysis caused by loss of motor functions of the nervous lumbar, sacral, or thoracic. The general term used to describe paraparese is incomplete paraplegia. Hypertension Heart Disease (HHD) is an abnormality of the spectrum which is an accumulation of blood pressure increase. HHD recovery can be achieved by administering antihypertensive therapy at every stage and condition. Hypertension is a factor that causes the greatest cause of CVD risk as HHD other CVD risk factors. The final phase of HHD is heart failure. Patient Mr. ZN, age 56 year old, entered the Mintoharjo Hospital on 25 November 2014 patient was diagnosed Paraparase Inferior and Hypertension Heart Desease (HHD). Patient has treated with Infusion RL, oxygen gas (O2), Neurodex, Mecobalamin, amlodipine, Cardace, Canderin, Spironolactone, Furosemide, Valdimex, ambroxol. In this case found the existence of Drug Related Problems (DRP) that areinteraction between cardace with canderin, both of them have pharmacodynamic synergism. That allows the interaction seriously and untreated complaint. [ABSTRACT FROM AUTHOR]
Databáze: Supplemental Index